Patrice Matchaba shares how a lifetime of experience helped shape an effort to address healthcare disparities.

Two Novartis leaders share their perspectives on digital health in 2020 – and the key trends to watch out for over the next 12 months.

Experimental treatments for Alzheimer’s disease put the amyloid cascade hypothesis to the test.

Novartis team perseveres to develop more personalized approach to breast cancer therapy.

Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.

The best treatment for multifaceted diseases like NASH may be combinations of drugs.

Lake Victoria in southwestern Kenya is on the front line in the fight against malaria, and Agnes Akoth is a key figure.

Advanced Accelerator Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.

Inspired by Emily Whitehead, along with other early patients treated with CAR-T cell therapy, Novartis embarked on a pioneering journey to reimagine cancer treatment. After 10 years, we continue to relentlessly pursue new science around cell and gene therapies to transform the lives of patients today and in the future.